Article Details

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

Retrieved on: 2021-04-14 10:52:30

Tags for this article:

Click the tags to see associated articles and topics

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development. View article details on hiswai:

Excerpt

Having access to a robust portfolio of antibodies for these coveted targets, as well as an extensive collection of unreleased monoclonal antibody ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo